Immunovant, Inc.
NasdaqGS:IMVT
$ 29.39
$-0.31 (-1.04%)
$ 29.39
$-0.31 (-1.04%)
End-of-day quote: 05/10/2024

IMVT - Immunovant Stock Prediction 2025 - 2030

5 years of reliable Immunovant stock forecast. The Wall Street analysts predict Buy for IMVT. See at a glance whether NasdaqGS:IMVT will rise in the future.

$0.00
Forecast 2023
$0.00 $32.30
Forecast 2025
$54.90
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$0.00 $32.30
Forecast 2030
$54.90
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.75
Price-to-book Ratio
6.28
Market Cap
4.32B
TEV
4.61 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$48.92

Immunovant Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Immunovant Stock Forecast 2023

$51.00

In the last five quarters, Immunovant’s Price Target has risen from $9.27 to $48.92 - a 427.72% increase. Thridteen analysts predict that Immunovant’s share price will increase in the coming year, reaching $51.00. This would represent an increase of 4.25%.

73.53%
73.53
Last update: 05/11/2024

Highest Price Target $56.00

Average Price Target $51.00

Lowest Price Target $40.00

Immunovant Stock Prediction 2025

Immunovant Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $26.92. A decrease of -8.41% compared to the previous month's estimate.

Immunovant Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $29.61. An increase of 0.75% compared to the previous month's estimate.

Immunovant Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $32.30. An increase of 9.91% compared to the previous month's estimate.

Immunovant Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $32.60. An increase of 10.94% compared to the previous month's estimate.

Immunovant Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $32.91. An increase of 11.96% compared to the previous month's estimate.

Immunovant Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $33.21. An increase of 12.99% compared to the previous month's estimate.

Immunovant Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $33.51. An increase of 14.01% compared to the previous month's estimate.

Immunovant Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $33.81. An increase of 15.04% compared to the previous month's estimate.

Immunovant Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $34.11. An increase of 16.06% compared to the previous month's estimate.

Immunovant Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $34.41. An increase of 17.09% compared to the previous month's estimate.

Immunovant Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $34.71. An increase of 18.11% compared to the previous month's estimate.

Immunovant Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $35.01. An increase of 19.14% compared to the previous month's estimate.

Immunovant Stock Forecast 2030

Stock Forecast for the Price of an Immunovant Share in Jan 2030.

In January 2030, analysts believe the stock price will be $53.98. An increase of 83.66% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Feb 2030.

In February 2030, analysts believe the stock price will be $54.44. An increase of 85.23% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Mar 2030.

In March 2030, analysts believe the stock price will be $54.90. An increase of 86.8% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Apr 2030.

In April 2030, analysts believe the stock price will be $55.41. An increase of 88.54% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in May 2030.

In May 2030, analysts believe the stock price will be $55.92. An increase of 90.28% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Jun 2030.

In June 2030, analysts believe the stock price will be $56.44. An increase of 92.02% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Jul 2030.

In July 2030, analysts believe the stock price will be $56.95. An increase of 93.76% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Aug 2030.

In August 2030, analysts believe the stock price will be $57.46. An increase of 95.51% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Sep 2030.

In September 2030, analysts believe the stock price will be $57.97. An increase of 97.25% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Oct 2030.

In October 2030, analysts believe the stock price will be $58.48. An increase of 98.99% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Nov 2030.

In November 2030, analysts believe the stock price will be $59.00. An increase of 100.73% compared to the previous month's estimate.

Stock Forecast for the Price of an Immunovant Share in Dec 2030.

In December 2030, analysts believe the stock price will be $59.51. An increase of 102.47% compared to the previous month's estimate.

P/E
0.00
Beta
0.75
Price-to-book Ratio
6.28
Market Cap
4.32B
TEV
4.61 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$48.92

Immunovant Analyst Ratings Frequently Asked Questions

Who are the analysts watching Immunovant, Inc.?

The following analysts have recently covered Immunovant:

BofA Global Research
Cantor Fitzgerald & Co.
Citigroup Inc
Citigroup Inc. Research
Guggenheim Securities, LLC
H.C. Wainwright & Co.
Leerink Partners LLC
LifeSci Capital, LLC
Marktfeld
Piper Sandler Companies
Raymond James & Associates
Stifel
UBS Investment Bank
Wells Fargo Securities, LLC
Wolfe Research, LLC.
J.P. Morgan
Goldman Sachs
Oppenheimer & Co. Inc.
CGS International
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Immunovant, Inc.?

The following sell-side analysts have recently covered Immunovant:

Gerberry, Jason Matthew
Chen, Louise Alesandra
Brill Bongero, Danielle Catherine
Semenkow, Samantha Lynn
Suneja, Yatin
Tsao, Douglas Dylan
Smith, Thomas Jonathan
Slutsky, Samuel Evan
Paraskevopoulos, Michail
Rahimi, Yasmeen
Thompson, Alexander
Bristow, Colin Nigel
Archila, Derek Christian
Chen, Gao Yi
Cheng, Lut Ming
Jenkins, Corinne
Gershell, Leland James
(This information refers to the last 90 days.)